Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
The Journal of Heart Transplantation|May 1, 1989
Are serum zinc and copper levels useful as acute rejection markers in heart transplantation?J P Domínguez, M Cháfer, A Alonso, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 29, 1999
Three cases of tuberculosis after heart transplantation in SpainR M Muñoz, L A Pulpón, M Yebra, et al.The Annals of Thoracic Surgery|May 1, 1996
Mitral valve replacement in a heart transplant recipient with iatrogenic mitral regurgitationM A Cavero, L A Pulpón, J A Rubio, et al.Annals of Internal Medicine|February 1, 1988
Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemiaP Valdivielso, J L Escolar, V Cuervas-Mons, et al.Transplantation Proceedings|September 10, 2003
Differential characteristics of heart transplantation in patients older than 60 yearsJ R Peraira, J Segovia, R Fuentes, et al.Transplantation Proceedings|September 10, 2003
Current induction immunosuppression and post-heart transplant lymphoproliferative disordersJ R Peraira, J Segovia, B Fuertes, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 1, 1993
Heart transplantation for cardiac angiosarcoma: should its indication be questioned?M G Crespo, L A Pulpón, G Pradas, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1994
Rhodococcus equi: first case in a heart transplant recipientJ Segovia, L A Pulpón, M G Crespo, et al.The Journal of Heart Transplantation|July 1, 1986
Combined transplantation of heart and liver from two different donors in a patient with familial type IIa hypercholesterolemiaD Figuera, J Ardaiz, V Martín-Júdez, et al.Revista Espanola De Cardiologia|November 1, 1994
[A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma]J A Rubio, L A Pulpón, M A Cavero, et al.Pageof 2